The rapid spread of the highly contagious Omicron variant of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) along with its high number of mutations in the spike gene …

The rapid emergence of SARS-CoV-2 variants challenges vaccination strategies. Here, we
collected 201 serum samples from persons with a single infection or multiple vaccine …

The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants
with potential resistance to existing drugs emphasizes the need for new therapeutic …

Griffithsin (GRFT), an algae-derived lectin, is one of the most potent viral entry inhibitors
discovered to date. It is currently being developed as a microbicide with broad-spectrum activity …

The rapid spread of the highly contagious Omicron variant of SARS-CoV-2 along with its high
number of mutations in the spike gene has raised alarm about the effectiveness of current …

The synthesis and full 3D structural characterization of nine new 1-benzenesulfonyl-2-methyl-1,2,3,4-tetrahydroquinoline
derivatives are reported. These belong to a library whose …

The frequent occurrence of multidrug resistance (MDR) conferred by the overexpression of
ATP-binding cassette (ABC) transporters ABCB1 and ABCG2 in cancer cells remains a …

Mutations in the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
variants can compromise the effectiveness of therapeutic antibodies. Most clinical-…

The simian immunodeficiency virus (SIV) challenge model of lentiviral infection is often used
as a model to human immunodeficiency virus type 1 (HIV-1) for studying vaccine mediated …

The SARS-CoV-2 Omicron variants were first detected in November 2021, and several
Omicron lineages (BA.1, BA.2, BA.3, BA.4, and BA.5) have since rapidly emerged. Studies …